Biomeme

Biomeme is a private US company pioneering mobile molecular diagnostics for biodefense and point-of-care healthcare. Founded in 2012, it has developed the 'Franklin' series of compact, high-performance thermocyclers that enable gold-standard PCR and isothermal testing outside the traditional lab. The company serves two primary markets: 1) military and first responders for rapid identification of biowarfare agents and 2) healthcare and research professionals for infectious disease detection and host-response profiling. Its vision centers on a 'One Health' approach, connecting human, animal, and environmental health through deployable genetic analysis.

Portable, automated PCR and isothermal amplification platforms (Franklin series) for field-deployable molecular testing. Includes compact thermocyclers, smartphone connectivity, and room-temperature-stable reagent kits for sample-to-answer analysis of pathogens and host mRNA biomarkers.

In biodefense, competes with other portable detection system providers (e.g., Smiths Detection, BioFire Defense). In healthcare diagnostics, faces established players like Abbott (ID NOW) and Cepheid (GeneXpert) for point-of-care molecular testing, and newer startups in the host-response field.